“The sustained efficacy of cannabis-based medicinal products positions them as a favorable analgesic option compared with opioids.”
Region: United Kingdom
“In short, we found no evidence that prenatal exposure to cannabis was associated with impaired cognitive or language development.”
Participants reported sustained improvements throughout the study – including improvements in migraine-related pain, disability, sleep, anxiety, depression, and overall quality of life.
Study participants reported improvements in their sleep quality, anxiety, depression, and health-related quality of life.
Patients who consumed cannabis products “demonstrated sustained and clinically meaningful improvements in depression, anxiety, health-related quality of life, and sleep quality over 24 months.”
Consistent with other studies, fibromyalgia patients report long-term improvements in their pain, anxiety, sleep, and overall quality of life following cannabis treatment.
Survey data reports that nearly one in five patients with endometriosis consume cannabis to manage their pain or other symptoms.
“The findings reveal a patient population experiencing transformative benefits from their treatment.”